Wound Care / Compression
UrgoStart is a soft-adherent foam dressing indicated for low to moderately exuding wounds (leg ulcers, pressure ulcers, diabetic foot ulcers).
UrgoStart speeds up wound healing X2 (1)
Clinically proven in a double blind randomised control trial (1)
Is cost effective (2)
With all the benefits of TLC:
- Pain-free dressing changes (3,4,5,6,7,8)
- Moist wound-healing (3,9)
- Stimulates fibroblasts proliferation by 45% (10,11)
Minimum duration of treatment 4-5 weeks
(1) Meaume S, et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Rep Reg. 2012; 20 (4) :p 500-511.
(2) An Economic Evaluation of UrgoStart® for Patients with Chronic Leg Ulcers in the United Kingdom. York University. Data on file. Urgo, 2011.
(3) Benbow M., Iossen G. A clinical evaluation of Urgotul to treat acute and chronic wounds. Br J Nurs 2004: 13 (2): 105-109.
(4) Meaume S. et al. Optimizing wound care with a new lipido-colloid dressing (Urgotul® Duo) Br J Nurs 2007: 16 (6): S4-12.
(5) Smith J. et al. Evaluation of Urgotul® plus K-four compression for venous leg ulcers, Br J Nurs 2004: 13 (6): S20-28.
(6) Fays S. et al. Leg ulcers and the Urgocell® Non-Adhesive wound dressing. Br J Nurs 2005: 14 (11):S15-20.
(7) Schmutz JL. et al. Evaluation of the nano-oligo saccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised controlled trial. International Wound Journal 2008; 5 (2):172-82.
(8) UrgoCell® Start TLC/ UrgoCell® TLC. Data on fi le, 2009. Urgo.
(9) Winter G.D. Formation of the scab and rate of epithelialisation of superfi cial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-294.
(10) Bernard F.X. et al. Stimulation of the proliferation of human dermal fi broblasts in vitro by a lipido-colloid dressing J Wound Care 2005; 14 (5): 215-220.
(11)UrgoStart®, UrgoStart® Contact. Data on fi le. 2011. Urgo.